Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib in Imatinib-Resistant GIST and Metastatic STS
NCT00385203Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in gastrointestinal stromal tumor (GIST), soft tissue sarcoma (STS), sponsored by AstraZeneca. Started Sep 2006; status: completed.
02
Drugs
cediranib
03
Conditions
gastrointestinal stromal tumor (GIST)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00385203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385203.